Taiwan invents chip able to identify asymptomatic COVID cases rapidly

Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19, study finds

Most COVID-19 ICU Survivors Still Experience Symptoms a Year After Admission

COVID vaccine boosters are proving a useful tool against Omicron, but scientists say that endless boosting might not be a practical or sustainable strategy (Nature)